Lv1
40 积分 2022-05-09 加入
Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2
2天前
已完结
Exploring the next generation of antibody-drug conjugates
1个月前
已完结
MAdCAM-1 targeting strategy can prevent colitic cancer carcinogenesis and progression via suppression of immune cell infiltration and inflammatory signals
3个月前
已完结
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers. A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers
3个月前
已完结
Comprehensive analysis of EphA2 in pan-cancer: A prognostic biomarker associated with cancer immunity
4个月前
已完结
EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities
4个月前
已完结
Stability of Ala 125 recombinant human interleukin-2 in solution
5个月前
已完结
Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis
7个月前
已完结
Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma
8个月前
已完结
皖公网安备34019202002308
